The Illness management and recovery (IMR) program is a standardized psychosocial intervention designed to help people with severe mental illness better manage their illness and achieve personally meaningful goals (1, 2) . IMR was created in conjunction with the National Implementing Evidence-Based Practices Project (3) , with the aim of incorporating empirically supported illness self-management strategies into a single program.
IMR is organized into topical modules, each of which requires several sessions to teach, using a combination of motivation-based, educational, and cognitive-behavioral strategies. The modules are premised on the stressvulnerability model (2, 4) and therefore include information on mitigating biological vulnerabilities and psychosocial stressors, as well as developing "recovery strategies" such as relapse prevention plans. The Third edition of IMR includes the following 11 modules: recovery, practical facts about mental illness, the stress-vulnerability model, building social support, drugs and alcohol, reducing relapses, coping with stress, coping with persistent symptoms, getting your needs met in the mental health system, and living a healthy lifestyle. IMR can be delivered in a group or individual format.
Resource materials have been developed to facilitate the implementation of IMR, including a practitioner's guide, the IMR Workbook (including educational handouts for each topic), the IMR fidelity scale, outcome measures, informational brochures for different stakeholders (e.g., consumers, family members, clinicians, policy makers), and introductory and demonstration videos.
Although the IMR program has strong empirical foundations by incorporating evidence-based strategies for improving illness self-management, unlike other practices in the National Implementing Evidence-Based Practices Project, IMR as a package had not been previously evaluated. Since the IMR program and resource materials became publically available for free on a SAMHSA website, IMR has been increasingly implemented throughout the U.S. and internationally, and has been the focus of growing research. This paper provides a systematic review of research on the IMR program including the effects of IMR on consumer outcomes and service utilization, implementation of IMR, and modifications to the program.
Methods
In June 2011 we searched EMBASE, MEDLINE, PsycINFO, CINAHL, and the Cochrane Library (i.e. CCTR, DARE, HTA), using the keywords "illness management and recovery," "wellness management and recovery" or "IMR" AND [("schizophrenia" OR "bipolar" OR "depression" OR "recovery" OR "mental health")] generating 37 references after duplicates were removed. We also searched for publications citing two seminal IMR articles (1, 2) resulting in 223 publications after removing duplicates. The inclusion criteria for our review included publications that dealt explicitly with IMR or described the program of study as an adaptation of IMR. Publications that simply described of the creation of the IMR program were excluded. We also excluded reports not published in peer-reviewed journals to ensure the highest scientific rigor. Twenty-six studies met inclusion criteria, including ten studies measuring consumer outcomes and sixteen studies examining implementation and/or adaptations of IMR. One study (Roe and colleagues; 5) was a qualitative follow-up of a prior study (6) and did not report unique quantitative consumer outcomes; however, because it provided implementation outcomes (completion rates) we included it in the review of implementation studies.
Results

Consumer Outcomes and Service Utilization
Randomized-Controlled Trials (RCTs). Three RCTs compared IMR to treatment as usual (6) (7) (8) (Table 1) . Hasson-Ohayon and colleagues (6) examined IMR in thirteen community agencies in Israel offering IMR for 8 months. Levitt and colleagues (7) examined IMR implemented within residential programming in New York City; follow-up was conducted post-treatment and six months later. The Illness Management and Recovery scales (IMRSs) were created in conjunction with the IMR Implementation Toolkit (9) in order to provide a practical measure of the progress of a consumer participating in IMR. Questions reflect specific IMR program targets, such as progress towards goals, knowledge of mental illness, having a relapse prevention plan, and substance use. Consumerreported IMRS scores improved more in IMR in both Färdig (8) and Levitt (7) (both medium effect sizes); overall, IMRS scores in Hasson-Ohayon (6) did not favor IMR until analyses were narrowed to sites with high IMR fidelity-at which point the IMR group showed better improvement ( Table 2) .
Consumers in IMR reported significant differences on four subscales of the Ways of Coping Scale in one RCT (8), but did not show any differences in coping in another (6) . However, consumers in IMR did not report greater improvement than controls on symptoms (Modified Colorado Symptom Index (7, 10)), recovery (Recovery Assessment Scale (8, 11) ), quality of life (Manchester short assessment of quality of life (8, 12) ), or social support (Multidimensional Scale of Perceived Social Support (6, 13)). Notably, there were no time effects for either IMR or control clients on these outcomes. Independent assessor evaluated outcomes were generally more encouraging. Consumers in IMR were rated as having greater symptom reduction than controls in both RCTs that examined this variable (7, 8) ; small and medium effect sizes, respectively), as well as better psychosocial functioning on an abbreviated version of Heinrich's Quality of Life Scale (7).
There were no significant differences between groups in hospitalization, as measured by self-report (7), record review (8) , and an unreported method (6) .
No study found improvements in employment (7) rate or changes in medication dosage (8) . Finally, clinicians in all three RCTs (6-8) rated consumers in IMR as improving more on the IMRS than those receiving usual care (effect sizes small and medium). Notably, though, clinicians were not blind to condition.
Quasi-Controlled and Pre-Post Trials. Three studies compared IMR to a non-randomized control group. Fujita and colleagues (14) compared an IMR group within a day treatment program in Japan to a convenience control group at another location. In two separate analyses (using partially overlapping samples) Salyers and colleagues (15, 16) Results from quasi-controlled and pre-post studies are reported when they differ from RCTs. These trials showed improvement over time for IMR on consumer-reported recovery (2, 17, 18) , generally measured by the RAS, whereas Färdig's RCT found no improvement for IMR consumers on this same scale. Consumer-reported psychiatric symptoms decreased in two quasicontrolled studies (2, 14) ; whereas Levitt (7) found no improvement. In short, the effects of IMR on consumer reported recovery and symptoms remains promising, but require further exploration.
Although satisfaction with services was not measured in any of the RCTs, three quasi-controlled studies (2, 15, 17) measured satisfaction, with only one (2) reporting significantly greater increases in satisfaction over time. graduates showed significant improvement on self-reported recovery and reduction in symptoms between baseline and following treatment (31) . These changes were maintained at a follow-up assessment conducted between 3-6 months following discharge.
Wellness Self-Management (WSM). Salerno and colleagues' (30)
adaption of IMR departs from traditional IMR in three key ways. Most significantly, consumers in WSM do not set long-term recovery goals. In addition, a greater emphasis was placed on "wellness action steps" rather than homework assignments within the program curriculum. WSM is currently offered in over improvement in goal progress; however, not enough information was provided to include this as an outcome study in our review above(30).
Factors Affecting Implementation
The Consolidated Framework for Implementation Research (35) Similarly, state technical assistance has been associated with increased reports of full implementation (32). Funding is also crucial. Rychener and colleagues (24) described that high expectations for productivity in terms of billable services make participation in non-billable activities that support IMR (e.g., supervision, steering committees, training) difficult. However, they reported this cost was partly offset by increased productivity due to IMR; clinicians who were previously providing brief case-management were able to deliver IMR services for longer periods of time.
Implementation Process. All published accounts of IMR implementation used a multifaceted implementation strategy involving training, IMR-specific supervision, technical assistance, and fidelity monitoring. Implementation support was generally very robust and spanned across domains of implementation.
Implementation across studies generally included some form of external facilitation, including academic detailing (24, 25, 37) or technical assistance (15, 17, 19, 30, 31) . Efforts in New York differ in the use of a learning collaborative (30) that served many of the same functions of a state technical assistance center, but was funded in part by financial commitments from participating agencies.
Individuals providing IMR. IMR has been generally provided by
professional clinicians, though some treatment settings utilize consumer providers (15, 18, 31) . Many implementation efforts began with a pilot group, generally with the most willing and enthusiastic clinicians, and expanded to additional programs and clinicians (24, 25, 30, 38) . Because IMR is a manualized program, clinicians must be willing to adapt to a more structured intervention (24) . Additionally, clinicians with paternalistic or medical-model philosophies may not be well-suited for IMR. For example, in the Rychener (24) implementation, the agency placed new emphasis on clinical supervision and fidelity monitoring that was difficult for clinicians unaccustomed to such a level of oversight.
However, despite a given clinician's preconceptions, IMR may provide a platform for paternalistic practitioners to challenge their beliefs and increase their recovery orientation (33, 34) .
Implementation Outcomes
IMR studies reported three types of implementation outcomes: feasibility, fidelity, and penetration (see Table 3 ). Feasibility--the extent to which a practice can be used or carried out within a setting (39)--is often measured by recruitment, retention, and participation rates (40). One factor relevant to feasibility is the program length. Although initially conceptualized as a three to six month program, more recent literature (17) has suggested IMR takes longer (9-12 months).
The median dropout rate across nine studies reporting (2, 6, 8, 14-17, 25, 41) was 24% and dropout rates were rather consistently within the 20%-30% range (2, 6, 15, 17, 18, 41) . In terms of lower dropout rates, Fujita and colleagues' (14) and Färdig and colleagues (8) found particularly low dropout rates (14% and 5%, respectively). Participants in Färdig's sample were selected based on consistent attendance, and training and consultation focused heavily on consumer engagement (Färdig, personal communication, 12/19/12) . Despite cross-study consistency in dropout rates, substantial variability exists between sites within some studies (e.g., 10%-50% (17), 24%-40% (2)).
Program completion was generally defined as having received all 10 modules; seven studies (2, 14-16, 18, 26, 41) reported completion rates, with a median rate of 63%. Unlike dropout rate, completion rates varied substantially between studies (range = 15%-86%). Salyers and colleagues (15) found a particularly low completion rate in their two year examination of ACT teams (15%); this rate only increased to 47% when retrospectively examining the full set of ACT-IMR programs within the state over a five year span (16) . A trend does appear between sites providing group versus individual format; all studies providing IMR in a group format were at or above the median completion rate.
Three studies (7, 8, 14) reported the percentage of sessions attended.
Average percent of sessions were 75% (8) and 82% (14) . Levitt (7) reported 54% of participants attended at least 21 out of 41 sessions of sessions.
Fidelity, or the level of adherence to the program model, was examined in seven studies. In the National Implementing Evidence-Based Practices Project (19) 50% of sites reached average scores meeting the criterion for "successful implementation" (i.e., greater than 4.0) (21) with an addition 25% obtaining "moderate implementation" (i.e., greater than 3.0). Hasson-Ohayon and colleagues' (6) multi-site RCT found cross-site variability in fidelity, ranging from 2.7 to 4.8, with eight out of eleven programs reaching "moderate" fidelity (42).
Importantly, Hasson-Ohayon found consumer IMR scale outcomes were stronger at high-fidelity sites than at low fidelity sites. All sites in four out of five subsequent studies (7, 14, 15, 17) reached fidelity greater than 4.
Penetration, or "the integration of a practice within a service setting," (40) can be measured in terms of the number of eligible consumers receiving a service or number of clinicians adopting the practice. Only two related studies examined penetration at the consumer level (15, 16) and found that only 26% and 29% of consumers on ACT teams received IMR.
In summary, IMR appears to be feasible to implement, with consumer acceptability within the range found in other evidence-based practices.
Completion rates were better for group IMR than for individual IMR. Nonetheless, both median dropout (about 24%) and completion rates (63%) leave much room for improvement. Acceptable rates of fidelity were found in later trials, but earlier, more geographically spread-out trials found substantial variability. Penetration was infrequently reported, but was poor in the few trials that did. (46)). Completion rates varied more than dropout rates, with the lowest rates found in two studies of IMR on ACT teams. Due to the severity of illness experienced by consumers on ACT teams, it is reasonable that these consumers may require a longer period to complete the IMR curriculum. These studies also found a lower hospitalization rate for ACT consumers receiving IMR, so it would be premature to determine that IMR is not useful for ACT consumers. It is also unclear what effects socioeconomic factors may have on acceptability (e.g., literacy, multiple role pressures) of IMR.
Fidelity was considered acceptable in all outcome studies in which it was measured, except in Hasson-Ohayon and colleagues (6) , where it varied across sites (consistent with fidelity results in the National Implementing EvidenceBased Practices project). Low fidelity was found in studies that spanned across state lines and one trial that was conducted in an inpatient setting. Geographical dispersion may be a limitation for consistently rigorous training and technical assistance.
Although fidelity is considered an important implementation outcome, the IMR fidelity scale has several limitations. First, the cut-point for "success" implementation has not been scientifically validated. Second, the scale focuses Notes: All studies focused on consumers with severe mental illness. 1 Randomized controlled trial comparing IMR to "treatment as usual." 2 IMR was provided in weekly groups, unless otherwise noted. 3 Two ACT teams randomly assigned to receive IMR training and peer support, two maintained treatment as usual. 4 Fujita et al. included a small wait--list control. Two consumers opted for individual IMR rather than group. 5 Based on weighted mean of time to program completion across sites. 6 Ns are total number of participants enrolled in the study. 
